Efficacy of Transcatheter Aortic Valve Implantation in Patients with Aortic Stenosis and Reduced LVEF

X. Luo,Z. Zhao,H. Chai,C. Zhang,Y. Liao,Q. Li,Y. Peng,W. Liu,X. Ren,Q. Meng,C. Chen,M. Chen,Y. Feng,D. Huang
DOI: https://doi.org/10.1007/s00059-014-4193-z
2015-01-01
Herz
Abstract:Transcatheter aortic valve implantation (TAVI) is safe and effective for patients with aortic stenosis (AS) who have a high operative risk. However, there is still debate on the effect of TAVI in AS patients with reduced left ventricular ejection fraction (REF). The objective of the review is to clarify the efficacy of TAVI and the impact of REF on the 30-day and midterm mortality in these patients.
What problem does this paper attempt to address?